Female Sexual-Arousal Interest Disorder
Candace syndrome, female sexual interest/arousal disorder. Specialty. Psychiatry, gynaecology. Female sexual arousal disorder (FSAD) is a disorder characterized by a persistent or recurrent inability to attain sexual arousal or to maintain arousal until the completion of a sexual activity.
Cluster Number:
Wiki Number: W082
Diagnosis: Female Sexual Arousal-Interest Disorder
US Patients:
World Patients:
Sex Ratio:
Age Onset:
Brain Area: smaller amygdala activity than for sexual activity without the disorder
Symptoms: cannot remain aroused through sexual activity
Progression: can be lifelong or acquired; general or situational
Causes: neurological or cardiovascular illnesses or fears; inadequate lubrication-swelling; loss of libido after hysterectomy
Medications:
Therapies:
Youtube Video: Reclaiming Female Sexual Desire
Amazon or Library Book: Sensate Focus in Sex Therapy
Click the book to link or order from Amazon.
Support Group: stretchforwomen.org (A Women-Only Organization)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Effect of COVID-19 infection on female sexual function: A prospective controlled studyby Ergul Demircivi on July 19, 2024
This prospective controlled study investigates the effects of coronavirus disease 2019 (COVID-19) on female sexual function, comparing recovered COVID-19-positive women with those uninfected by the virus. It aims to elucidate the broader impacts on sexual health and psychological well-being. This prospective controlled study included nonpregnant women of reproductive age and their partners, divided into COVID-19- positive (recovered) and negative groups. Data collection took place on average 6...
- Endometriosis and sexual disorders: the effect of surgical and medical treatment, a multicentre cross-sectional studyby Tommaso Capezzuoli on July 15, 2024
CONCLUSIONS: Patients with endometriosis are at risk for FSD, encompassing not only dyspareunia, but all domains of sexual function. Hormonal treatments do not result in improvement in sexual symptoms.
- Sex moderates the effect of anhedonia on parietal alpha asymmetryby Resh S Gupta on July 13, 2024
Anhedonia, a transdiagnostic symptom present in many neuropsychiatric disorders, differs in males and females. Parietal EEG alpha asymmetry is associated with reduced arousal and low positive emotionality, and is, therefore, a promising neurophysiologic biomarker of anhedonia. To date, however, no prior studies have determined whether this measure captures sex differences in anhedonic expression. This preliminary study (N = 36) investigated whether anhedonia severity is associated with EEG...
- Systemic testosterone for the treatment of female sexual interest and arousal disorder (FSIAD) in the postmenopauseby Laura Ribera Torres on June 24, 2024
CONCLUSIONS: Despite having testosterone as a valuable tool, therapeutic strategies are lacking in the pharmacological field of HSDD/FSIAD. Neuroimaging studies could provide valuable information regarding the sexual desire substrate and suggest the potential application of already approved drugs for women with a good safety profile. The use of validated instruments for HSDD in postmenopausal women, considering the level of distress, is necessary to be able to draw robust conclusions on the...